These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 3874598)
1. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598 [TBL] [Abstract][Full Text] [Related]
2. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130 [TBL] [Abstract][Full Text] [Related]
3. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic. Angehrn P Chemotherapy; 1985; 31(6):440-50. PubMed ID: 3935396 [TBL] [Abstract][Full Text] [Related]
4. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams]. Le Noc P; Croize J; Le Noc D Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846 [TBL] [Abstract][Full Text] [Related]
5. In-vitro evaluation of carumonam (Ro 17-2301). Stobberingh EE; Houben AW; van Boven CP J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Neu HC; Chin NX; Neu NM Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845 [TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria]. Soussy CJ; Le Van Thoi J; Duval JR Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745 [TBL] [Abstract][Full Text] [Related]
8. In-vitro antibacterial activity of AMA-1080. Matsuda K; Hamana Y; Inoue M; Mitsuhashi S J Antimicrob Chemother; 1985 Nov; 16(5):539-47. PubMed ID: 3878360 [TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity and beta-lactamase stability of carumonam. Neu HC; Chin NX; Labthavikul P J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143 [TBL] [Abstract][Full Text] [Related]
10. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates. Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro antimicrobial activity of carumonam, a new monocyclic beta-lactam. Smith BR; LeFrock JL; McCloskey RV; Donato JB; Weber SJ; Joseph WS Antimicrob Agents Chemother; 1986 Feb; 29(2):346-9. PubMed ID: 3087280 [TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams. Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021 [TBL] [Abstract][Full Text] [Related]
14. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology. Nakao M; Kondo M; Imada A J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273 [TBL] [Abstract][Full Text] [Related]
15. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. Phillips I; Warren C; Shannon K; King A; Hanslo D J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967 [TBL] [Abstract][Full Text] [Related]
16. [Effects of beta-lactamases on the antibacterial activity of carumonam and aztreonam against Klebsiella sp. in comparison with 4 other beta-lactams]. Labia R; Morand A; Pitton JS; Philippin JL; Fournier P Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):796-9. PubMed ID: 3309817 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics. Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718 [TBL] [Abstract][Full Text] [Related]
18. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [TBL] [Abstract][Full Text] [Related]
19. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A; Mattina R; Cocuzza CE Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [TBL] [Abstract][Full Text] [Related]